TLR9 and BAFF: Their expression in patients with IgA nephropathy

Wei Wei Li, Xiaofei Peng, Yuyuan Liu, Hong Liu, Fuyou Liu, Liyu He, Yang Liu, Fan Zhang, Chunyan Guo, Guochun Chen, Lei Zhang, Zheng Dong, Youming Peng

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Since it was first described in 1968, immunoglobulin (Ig)A nephropathy (IgAN) has become the most commonly diagnosed form of primary glomerular disease worldwide. A number of reports have shown that toll-like receptor 9 (TLR9) and B-cell activating factor (BAFF) may be associated with IgAN; however, sufficient evidence has not yet to be delivered. In the present study, serum levels of BAFF as well as TLR9 mRNA and protein levels in peripheral blood mononuclear cells (PBMCs) were assessed. Expression of TLR9 mRNA in PBMCs was examined by quantitative polymerase chain reaction and the TLR9 protein was determined by western blot analysis. The levels of serum BAFF and IgA1 were determined by specific ELISA. Serum levels of BAFF and IgA1 as well as levels of TLR9 mRNA and protein in PMBCs were significantly higher in patients with IgAN compared with patients with minimal glomerular abnormalities (P<0.05, P<0.01, P<0.01 and P<0.01, respectively) and normal controls (P<0.01, P<0.01, P<0.05 and P<0.01, respectively). A correlation and regression analysis was performed to determine the pathogenesis of IgAN. In patients with IgAN, serum levels of BAFF were positively correlated with IgA1 levels (rp, 0.515; P<0.01) and mesangial IgA deposition density (rp, 0.746; P<0.01). Expression levels of TLR9 protein in PBMCs of IgAN patients were positively correlated with levels of serum BAFF (rp, 0.444; P<0.05) and IgA1 (rp, 0.633; P<0.01). These results suggested that overexpression of TLR9 mRNA and protein in PBMCs and elevated levels of serum BAFF may be associated with over-expression of serum IgA1, and, furthermore, may have a role in the development of IgAN.

Original languageEnglish (US)
Pages (from-to)1469-1474
Number of pages6
JournalMolecular Medicine Reports
Volume10
Issue number3
DOIs
StatePublished - Sep 2014

Fingerprint

Toll-Like Receptor 9
Immunoglobulin A
Serum
Blood Cells
Blood
Messenger RNA
Proteins
IGA Glomerulonephritis
B-Cell Activating Factor
Polymerase chain reaction
Regression analysis
Western Blotting
Enzyme-Linked Immunosorbent Assay
Regression Analysis
Polymerase Chain Reaction

Keywords

  • BAFF
  • IgA nephropathy
  • IgA1
  • TLR9

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Oncology
  • Cancer Research

Cite this

Li, W. W., Peng, X., Liu, Y., Liu, H., Liu, F., He, L., ... Peng, Y. (2014). TLR9 and BAFF: Their expression in patients with IgA nephropathy. Molecular Medicine Reports, 10(3), 1469-1474. https://doi.org/10.3892/mmr.2014.2359

TLR9 and BAFF : Their expression in patients with IgA nephropathy. / Li, Wei Wei; Peng, Xiaofei; Liu, Yuyuan; Liu, Hong; Liu, Fuyou; He, Liyu; Liu, Yang; Zhang, Fan; Guo, Chunyan; Chen, Guochun; Zhang, Lei; Dong, Zheng; Peng, Youming.

In: Molecular Medicine Reports, Vol. 10, No. 3, 09.2014, p. 1469-1474.

Research output: Contribution to journalArticle

Li, WW, Peng, X, Liu, Y, Liu, H, Liu, F, He, L, Liu, Y, Zhang, F, Guo, C, Chen, G, Zhang, L, Dong, Z & Peng, Y 2014, 'TLR9 and BAFF: Their expression in patients with IgA nephropathy', Molecular Medicine Reports, vol. 10, no. 3, pp. 1469-1474. https://doi.org/10.3892/mmr.2014.2359
Li, Wei Wei ; Peng, Xiaofei ; Liu, Yuyuan ; Liu, Hong ; Liu, Fuyou ; He, Liyu ; Liu, Yang ; Zhang, Fan ; Guo, Chunyan ; Chen, Guochun ; Zhang, Lei ; Dong, Zheng ; Peng, Youming. / TLR9 and BAFF : Their expression in patients with IgA nephropathy. In: Molecular Medicine Reports. 2014 ; Vol. 10, No. 3. pp. 1469-1474.
@article{15a7dd6d096e4e7e9a6d135247b4b5d8,
title = "TLR9 and BAFF: Their expression in patients with IgA nephropathy",
abstract = "Since it was first described in 1968, immunoglobulin (Ig)A nephropathy (IgAN) has become the most commonly diagnosed form of primary glomerular disease worldwide. A number of reports have shown that toll-like receptor 9 (TLR9) and B-cell activating factor (BAFF) may be associated with IgAN; however, sufficient evidence has not yet to be delivered. In the present study, serum levels of BAFF as well as TLR9 mRNA and protein levels in peripheral blood mononuclear cells (PBMCs) were assessed. Expression of TLR9 mRNA in PBMCs was examined by quantitative polymerase chain reaction and the TLR9 protein was determined by western blot analysis. The levels of serum BAFF and IgA1 were determined by specific ELISA. Serum levels of BAFF and IgA1 as well as levels of TLR9 mRNA and protein in PMBCs were significantly higher in patients with IgAN compared with patients with minimal glomerular abnormalities (P<0.05, P<0.01, P<0.01 and P<0.01, respectively) and normal controls (P<0.01, P<0.01, P<0.05 and P<0.01, respectively). A correlation and regression analysis was performed to determine the pathogenesis of IgAN. In patients with IgAN, serum levels of BAFF were positively correlated with IgA1 levels (rp, 0.515; P<0.01) and mesangial IgA deposition density (rp, 0.746; P<0.01). Expression levels of TLR9 protein in PBMCs of IgAN patients were positively correlated with levels of serum BAFF (rp, 0.444; P<0.05) and IgA1 (rp, 0.633; P<0.01). These results suggested that overexpression of TLR9 mRNA and protein in PBMCs and elevated levels of serum BAFF may be associated with over-expression of serum IgA1, and, furthermore, may have a role in the development of IgAN.",
keywords = "BAFF, IgA nephropathy, IgA1, TLR9",
author = "Li, {Wei Wei} and Xiaofei Peng and Yuyuan Liu and Hong Liu and Fuyou Liu and Liyu He and Yang Liu and Fan Zhang and Chunyan Guo and Guochun Chen and Lei Zhang and Zheng Dong and Youming Peng",
year = "2014",
month = "9",
doi = "10.3892/mmr.2014.2359",
language = "English (US)",
volume = "10",
pages = "1469--1474",
journal = "Molecular Medicine Reports",
issn = "1791-2997",
publisher = "Spandidos Publications",
number = "3",

}

TY - JOUR

T1 - TLR9 and BAFF

T2 - Their expression in patients with IgA nephropathy

AU - Li, Wei Wei

AU - Peng, Xiaofei

AU - Liu, Yuyuan

AU - Liu, Hong

AU - Liu, Fuyou

AU - He, Liyu

AU - Liu, Yang

AU - Zhang, Fan

AU - Guo, Chunyan

AU - Chen, Guochun

AU - Zhang, Lei

AU - Dong, Zheng

AU - Peng, Youming

PY - 2014/9

Y1 - 2014/9

N2 - Since it was first described in 1968, immunoglobulin (Ig)A nephropathy (IgAN) has become the most commonly diagnosed form of primary glomerular disease worldwide. A number of reports have shown that toll-like receptor 9 (TLR9) and B-cell activating factor (BAFF) may be associated with IgAN; however, sufficient evidence has not yet to be delivered. In the present study, serum levels of BAFF as well as TLR9 mRNA and protein levels in peripheral blood mononuclear cells (PBMCs) were assessed. Expression of TLR9 mRNA in PBMCs was examined by quantitative polymerase chain reaction and the TLR9 protein was determined by western blot analysis. The levels of serum BAFF and IgA1 were determined by specific ELISA. Serum levels of BAFF and IgA1 as well as levels of TLR9 mRNA and protein in PMBCs were significantly higher in patients with IgAN compared with patients with minimal glomerular abnormalities (P<0.05, P<0.01, P<0.01 and P<0.01, respectively) and normal controls (P<0.01, P<0.01, P<0.05 and P<0.01, respectively). A correlation and regression analysis was performed to determine the pathogenesis of IgAN. In patients with IgAN, serum levels of BAFF were positively correlated with IgA1 levels (rp, 0.515; P<0.01) and mesangial IgA deposition density (rp, 0.746; P<0.01). Expression levels of TLR9 protein in PBMCs of IgAN patients were positively correlated with levels of serum BAFF (rp, 0.444; P<0.05) and IgA1 (rp, 0.633; P<0.01). These results suggested that overexpression of TLR9 mRNA and protein in PBMCs and elevated levels of serum BAFF may be associated with over-expression of serum IgA1, and, furthermore, may have a role in the development of IgAN.

AB - Since it was first described in 1968, immunoglobulin (Ig)A nephropathy (IgAN) has become the most commonly diagnosed form of primary glomerular disease worldwide. A number of reports have shown that toll-like receptor 9 (TLR9) and B-cell activating factor (BAFF) may be associated with IgAN; however, sufficient evidence has not yet to be delivered. In the present study, serum levels of BAFF as well as TLR9 mRNA and protein levels in peripheral blood mononuclear cells (PBMCs) were assessed. Expression of TLR9 mRNA in PBMCs was examined by quantitative polymerase chain reaction and the TLR9 protein was determined by western blot analysis. The levels of serum BAFF and IgA1 were determined by specific ELISA. Serum levels of BAFF and IgA1 as well as levels of TLR9 mRNA and protein in PMBCs were significantly higher in patients with IgAN compared with patients with minimal glomerular abnormalities (P<0.05, P<0.01, P<0.01 and P<0.01, respectively) and normal controls (P<0.01, P<0.01, P<0.05 and P<0.01, respectively). A correlation and regression analysis was performed to determine the pathogenesis of IgAN. In patients with IgAN, serum levels of BAFF were positively correlated with IgA1 levels (rp, 0.515; P<0.01) and mesangial IgA deposition density (rp, 0.746; P<0.01). Expression levels of TLR9 protein in PBMCs of IgAN patients were positively correlated with levels of serum BAFF (rp, 0.444; P<0.05) and IgA1 (rp, 0.633; P<0.01). These results suggested that overexpression of TLR9 mRNA and protein in PBMCs and elevated levels of serum BAFF may be associated with over-expression of serum IgA1, and, furthermore, may have a role in the development of IgAN.

KW - BAFF

KW - IgA nephropathy

KW - IgA1

KW - TLR9

UR - http://www.scopus.com/inward/record.url?scp=84905440776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905440776&partnerID=8YFLogxK

U2 - 10.3892/mmr.2014.2359

DO - 10.3892/mmr.2014.2359

M3 - Article

C2 - 24993857

AN - SCOPUS:84905440776

VL - 10

SP - 1469

EP - 1474

JO - Molecular Medicine Reports

JF - Molecular Medicine Reports

SN - 1791-2997

IS - 3

ER -